Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,900 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recovery of microcirculation after intracoronary infusion of bone marrow mononuclear cells or peripheral blood mononuclear cells in patients treated by primary percutaneous coronary intervention the Doppler substudy of the Hebe trial.
van der Laan AM, Hirsch A, Haeck JD, Nijveldt R, Delewi R, Biemond BJ, Tijssen JG, Marques KM, Zijlstra F, van Rossum AC, Piek JJ. van der Laan AM, et al. Among authors: hirsch a. JACC Cardiovasc Interv. 2011 Aug;4(8):913-20. doi: 10.1016/j.jcin.2011.05.005. JACC Cardiovasc Interv. 2011. PMID: 21851907 Free article. Clinical Trial.
Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial.
Hirsch A, Nijveldt R, van der Vleuten PA, Biemond BJ, Doevendans PA, van Rossum AC, Tijssen JG, Zijlstra F, Piek JJ; HEBE investigators. Hirsch A, et al. Am Heart J. 2006 Sep;152(3):434-41. doi: 10.1016/j.ahj.2006.02.007. Am Heart J. 2006. PMID: 16923409
Long-term outcome after an early invasive versus selective invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow-up study.
Hirsch A, Windhausen F, Tijssen JG, Verheugt FW, Cornel JH, de Winter RJ; Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) investigators. Hirsch A, et al. Lancet. 2007 Mar 10;369(9564):827-835. doi: 10.1016/S0140-6736(07)60410-3. Lancet. 2007. PMID: 17350451 Clinical Trial.
N-terminal pro-brain natriuretic peptide for additional risk stratification in patients with non-ST-elevation acute coronary syndrome and an elevated troponin T: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy.
Windhausen F, Hirsch A, Sanders GT, Cornel J, Fischer J, van Straalen JP, Tijssen JG, Verheugt FW, de Winter RJ; Invasive versus Conservative Treatment in Unstable coronary Syndromes investigators. Windhausen F, et al. Among authors: hirsch a. Am Heart J. 2007 Apr;153(4):485-92. doi: 10.1016/j.ahj.2006.12.012. Am Heart J. 2007. PMID: 17383283 Clinical Trial.
ST-segment deviation on the admission electrocardiogram, treatment strategy, and outcome in non-ST-elevation acute coronary syndromes A substudy of the Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) Trial.
Windhausen F, Hirsch A, Tijssen JG, Cornel JH, Verheugt FW, Klees MI, de Winter RJ; Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) investigators. Windhausen F, et al. Among authors: hirsch a. J Electrocardiol. 2007 Sep-Oct;40(5):408-15. doi: 10.1016/j.jelectrocard.2007.05.008. Epub 2007 Jul 2. J Electrocardiol. 2007. PMID: 17604045 Clinical Trial.
Cost-effectiveness of early versus selectively invasive strategy in patients with acute coronary syndromes without ST-segment elevation.
Dijksman LM, Hirsch A, Windhausen F, Asselman FF, Tijssen JG, Dijkgraaf MG, de Winter RJ; Invasive versus Conservative Treatment in Unstable Coronary Syndromes Investigators. Dijksman LM, et al. Among authors: hirsch a. Int J Cardiol. 2009 Jan 9;131(2):204-11. doi: 10.1016/j.ijcard.2007.10.019. Epub 2008 Jan 15. Int J Cardiol. 2009. PMID: 18199496 Clinical Trial.
Intracoronary infusion of autologous mononuclear bone marrow cells in patients with acute myocardial infarction treated with primary PCI: Pilot study of the multicenter HEBE trial.
Hirsch A, Nijveldt R, van der Vleuten PA, Tio RA, van der Giessen WJ, Marques KM, Doevendans PA, Waltenberger J, Ten Berg JM, Aengevaeren WR, Biemond BJ, Tijssen JG, van Rossum AC, Piek JJ, Zijlstra F. Hirsch A, et al. Catheter Cardiovasc Interv. 2008 Feb 15;71(3):273-81. doi: 10.1002/ccd.21337. Catheter Cardiovasc Interv. 2008. PMID: 18288734 Clinical Trial.
Relation between the assessment of microvascular injury by cardiovascular magnetic resonance and coronary Doppler flow velocity measurements in patients with acute anterior wall myocardial infarction.
Hirsch A, Nijveldt R, Haeck JD, Beek AM, Koch KT, Henriques JP, van der Schaaf RJ, Vis MM, Baan J Jr, de Winter RJ, Tijssen JG, van Rossum AC, Piek JJ. Hirsch A, et al. J Am Coll Cardiol. 2008 Jun 10;51(23):2230-8. doi: 10.1016/j.jacc.2008.01.064. J Am Coll Cardiol. 2008. PMID: 18534269 Free article.
1,900 results